HK Stock MarketDetailed Quotes

00390 CHINA RAILWAY

Watchlist
  • 3.980
  • +0.100+2.58%
Market Closed Nov 1 16:08 CST
98.51BMarket Cap2.96P/E (TTM)

CHINA RAILWAY Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
-7.30%818.48B
-7.83%544.52B
-2.56%265.01B
9.45%1.26T
4.09%882.92B
5.38%590.77B
2.04%271.97B
7.55%1.15T
10.45%848.18B
12.52%560.59B
Special items of operating revenue
12.54%1.8B
----
-2.56%634.19M
----
-14.16%1.6B
----
16.13%650.83M
----
-18.54%1.87B
----
Operating income
-7.26%820.28B
-7.83%544.52B
-2.56%265.65B
9.45%1.26T
4.05%884.52B
5.38%590.77B
2.07%272.62B
7.55%1.15T
10.37%850.05B
12.52%560.59B
Cost of sales
----
7.80%-497.77B
----
-9.11%-1.14T
----
-5.02%-539.86B
----
-7.79%-1.05T
----
-12.61%-514.04B
Operating expenses
7.00%-746.49B
7.80%-497.77B
2.21%-242.26B
-9.11%-1.14T
-3.81%-802.67B
-5.02%-539.86B
-2.15%-247.74B
-7.79%-1.05T
-10.82%-773.19B
-12.61%-514.04B
Gross profit
-9.85%73.79B
-8.15%46.76B
-6.02%23.38B
12.67%122.69B
6.48%81.85B
9.36%50.91B
1.23%24.88B
5.32%108.89B
5.98%76.86B
11.45%46.55B
Selling expenses
0.81%-4.38B
5.15%-2.91B
10.82%-1.35B
-8.25%-6.85B
-6.27%-4.42B
-13.30%-3.07B
-12.83%-1.51B
-6.39%-6.33B
-8.09%-4.16B
-14.13%-2.71B
Administrative expenses
6.53%-17.63B
1.72%-12.9B
-4.18%-6.71B
-9.64%-28.96B
-4.90%-18.86B
-7.39%-13.13B
-4.38%-6.44B
-3.84%-26.41B
-4.54%-17.98B
2.32%-12.23B
Research and development expenses
9.68%-16.09B
10.36%-9.23B
9.64%-3.47B
-8.14%-30B
-12.50%-17.81B
-14.60%-10.29B
14.27%-3.84B
-12.06%-27.74B
-15.84%-15.83B
---8.98B
Profit from asset sales
-63.76%84.15M
----
-40.01%149.42M
----
1,357.38%232.19M
----
883.22%249.08M
----
-107.23%-18.47M
----
Revaluation surplus
118.59%61.62M
----
-83.41%-84.69M
----
-3.69%-331.53M
----
60.29%-46.18M
----
-49.59%-319.74M
----
-Changes in the fair value of other assets
118.59%61.62M
----
-83.41%-84.69M
----
-3.69%-331.53M
----
60.29%-46.18M
----
-49.59%-319.74M
----
Impairment and provision
-25.00%-2.92B
5.34%-1.76B
39.87%-665.18M
-113.79%-7.15B
37.04%-2.34B
-31.28%-1.86B
-30.50%-1.11B
38.97%-3.34B
12.68%-3.71B
-2.24%-1.41B
-Other impairment is provision
-25.00%-2.92B
5.34%-1.76B
39.87%-665.18M
-113.79%-7.15B
37.04%-2.34B
-31.28%-1.86B
-30.50%-1.11B
38.97%-3.34B
12.68%-3.71B
-2.24%-1.41B
Operating interest expense
-18.74%-356.03M
----
-29.89%-181.29M
----
-66.02%-299.83M
----
-774.96%-139.57M
----
68.01%-180.6M
----
Special items of operating profit
-11.22%1.22B
-718.68%-563M
-25.65%844.91M
-101.42%-2.56B
-35.60%1.37B
-74.00%91M
24.46%1.14B
67.60%-1.27B
59.90%2.13B
104.80%350M
Operating profit
-13.96%30.34B
-14.36%19.4B
-8.82%10.83B
7.71%47.17B
8.16%35.26B
5.01%22.66B
6.30%11.88B
15.72%43.79B
6.50%32.6B
18.51%21.58B
Financing income
----
3.35%4.45B
----
21.34%8.71B
----
45.57%4.3B
----
17.61%7.18B
----
32.20%2.96B
Financing cost
-1.75%-3.32B
-3.65%-5.74B
9.44%-1.02B
-24.17%-11.89B
-56.34%-3.27B
-34.31%-5.54B
-16.04%-1.13B
-25.76%-9.58B
33.69%-2.09B
-37.92%-4.12B
Share of profits of associates
----
-23.96%1.66B
----
-1.44%4.67B
----
6.63%2.19B
----
24.28%4.73B
----
74.55%2.05B
Share of profit from joint venture company
----
66.46%-214M
----
25.19%-1.08B
----
-13.12%-638M
----
-183.43%-1.44B
----
-161.11%-564M
Special items of earning before tax
1,116.78%209.52M
----
128.49%51.13M
----
-76.88%17.22M
----
-85.94%22.38M
----
123.33%74.49M
----
Earning before tax
-14.95%27.23B
-14.85%19.56B
-8.47%9.86B
6.46%47.58B
4.66%32.01B
4.91%22.97B
3.97%10.77B
12.76%44.69B
12.69%30.59B
18.93%21.9B
Tax
16.30%-4.77B
17.35%-3.89B
3.81%-1.83B
-2.25%-9.94B
-2.55%-5.69B
7.49%-4.71B
7.23%-1.91B
-6.10%-9.73B
-14.17%-5.55B
-25.28%-5.09B
After-tax profit from continuing operations
-14.66%22.46B
-14.21%15.67B
-9.47%8.03B
7.64%37.64B
5.13%26.32B
8.66%18.26B
6.74%8.87B
14.76%34.97B
12.36%25.04B
17.13%16.81B
After-tax profit from non-continuing business
--0
----
----
----
--0
----
----
----
--0
----
Earning after tax
-14.66%22.46B
-14.21%15.67B
-9.47%8.03B
7.64%37.64B
5.13%26.32B
8.66%18.26B
6.74%8.87B
14.76%34.97B
12.36%25.04B
17.13%16.81B
Minority profit
-18.07%1.89B
-31.36%1.39B
-44.75%545.85M
12.45%4.15B
13.69%2.31B
19.61%2.03B
37.32%987.93M
29.52%3.69B
24.21%2.03B
34.90%1.69B
Adjustment items of profit attributable to shareholders
----
----
----
----
----
----
--2K
----
----
----
Profit attributable to shareholders
-14.33%20.57B
-12.07%14.28B
-5.04%7.48B
7.07%33.48B
4.37%24.01B
7.44%16.24B
3.84%7.88B
13.23%31.27B
11.43%23.01B
15.43%15.12B
Basic earnings per share
-14.13%0.784
-12.07%0.532
-5.25%0.289
8.01%1.294
4.82%0.913
9.80%0.605
3.74%0.305
15.53%1.198
19.15%0.871
21.37%0.551
Diluted earnings per share
-14.13%0.784
-12.07%0.532
-5.25%0.289
7.85%1.292
4.82%0.913
9.80%0.605
3.74%0.305
15.53%1.198
19.15%0.871
21.37%0.551
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)
--
--
--
PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover -7.30%818.48B-7.83%544.52B-2.56%265.01B9.45%1.26T4.09%882.92B5.38%590.77B2.04%271.97B7.55%1.15T10.45%848.18B12.52%560.59B
Special items of operating revenue 12.54%1.8B-----2.56%634.19M-----14.16%1.6B----16.13%650.83M-----18.54%1.87B----
Operating income -7.26%820.28B-7.83%544.52B-2.56%265.65B9.45%1.26T4.05%884.52B5.38%590.77B2.07%272.62B7.55%1.15T10.37%850.05B12.52%560.59B
Cost of sales ----7.80%-497.77B-----9.11%-1.14T-----5.02%-539.86B-----7.79%-1.05T-----12.61%-514.04B
Operating expenses 7.00%-746.49B7.80%-497.77B2.21%-242.26B-9.11%-1.14T-3.81%-802.67B-5.02%-539.86B-2.15%-247.74B-7.79%-1.05T-10.82%-773.19B-12.61%-514.04B
Gross profit -9.85%73.79B-8.15%46.76B-6.02%23.38B12.67%122.69B6.48%81.85B9.36%50.91B1.23%24.88B5.32%108.89B5.98%76.86B11.45%46.55B
Selling expenses 0.81%-4.38B5.15%-2.91B10.82%-1.35B-8.25%-6.85B-6.27%-4.42B-13.30%-3.07B-12.83%-1.51B-6.39%-6.33B-8.09%-4.16B-14.13%-2.71B
Administrative expenses 6.53%-17.63B1.72%-12.9B-4.18%-6.71B-9.64%-28.96B-4.90%-18.86B-7.39%-13.13B-4.38%-6.44B-3.84%-26.41B-4.54%-17.98B2.32%-12.23B
Research and development expenses 9.68%-16.09B10.36%-9.23B9.64%-3.47B-8.14%-30B-12.50%-17.81B-14.60%-10.29B14.27%-3.84B-12.06%-27.74B-15.84%-15.83B---8.98B
Profit from asset sales -63.76%84.15M-----40.01%149.42M----1,357.38%232.19M----883.22%249.08M-----107.23%-18.47M----
Revaluation surplus 118.59%61.62M-----83.41%-84.69M-----3.69%-331.53M----60.29%-46.18M-----49.59%-319.74M----
-Changes in the fair value of other assets 118.59%61.62M-----83.41%-84.69M-----3.69%-331.53M----60.29%-46.18M-----49.59%-319.74M----
Impairment and provision -25.00%-2.92B5.34%-1.76B39.87%-665.18M-113.79%-7.15B37.04%-2.34B-31.28%-1.86B-30.50%-1.11B38.97%-3.34B12.68%-3.71B-2.24%-1.41B
-Other impairment is provision -25.00%-2.92B5.34%-1.76B39.87%-665.18M-113.79%-7.15B37.04%-2.34B-31.28%-1.86B-30.50%-1.11B38.97%-3.34B12.68%-3.71B-2.24%-1.41B
Operating interest expense -18.74%-356.03M-----29.89%-181.29M-----66.02%-299.83M-----774.96%-139.57M----68.01%-180.6M----
Special items of operating profit -11.22%1.22B-718.68%-563M-25.65%844.91M-101.42%-2.56B-35.60%1.37B-74.00%91M24.46%1.14B67.60%-1.27B59.90%2.13B104.80%350M
Operating profit -13.96%30.34B-14.36%19.4B-8.82%10.83B7.71%47.17B8.16%35.26B5.01%22.66B6.30%11.88B15.72%43.79B6.50%32.6B18.51%21.58B
Financing income ----3.35%4.45B----21.34%8.71B----45.57%4.3B----17.61%7.18B----32.20%2.96B
Financing cost -1.75%-3.32B-3.65%-5.74B9.44%-1.02B-24.17%-11.89B-56.34%-3.27B-34.31%-5.54B-16.04%-1.13B-25.76%-9.58B33.69%-2.09B-37.92%-4.12B
Share of profits of associates -----23.96%1.66B-----1.44%4.67B----6.63%2.19B----24.28%4.73B----74.55%2.05B
Share of profit from joint venture company ----66.46%-214M----25.19%-1.08B-----13.12%-638M-----183.43%-1.44B-----161.11%-564M
Special items of earning before tax 1,116.78%209.52M----128.49%51.13M-----76.88%17.22M-----85.94%22.38M----123.33%74.49M----
Earning before tax -14.95%27.23B-14.85%19.56B-8.47%9.86B6.46%47.58B4.66%32.01B4.91%22.97B3.97%10.77B12.76%44.69B12.69%30.59B18.93%21.9B
Tax 16.30%-4.77B17.35%-3.89B3.81%-1.83B-2.25%-9.94B-2.55%-5.69B7.49%-4.71B7.23%-1.91B-6.10%-9.73B-14.17%-5.55B-25.28%-5.09B
After-tax profit from continuing operations -14.66%22.46B-14.21%15.67B-9.47%8.03B7.64%37.64B5.13%26.32B8.66%18.26B6.74%8.87B14.76%34.97B12.36%25.04B17.13%16.81B
After-tax profit from non-continuing business --0--------------0--------------0----
Earning after tax -14.66%22.46B-14.21%15.67B-9.47%8.03B7.64%37.64B5.13%26.32B8.66%18.26B6.74%8.87B14.76%34.97B12.36%25.04B17.13%16.81B
Minority profit -18.07%1.89B-31.36%1.39B-44.75%545.85M12.45%4.15B13.69%2.31B19.61%2.03B37.32%987.93M29.52%3.69B24.21%2.03B34.90%1.69B
Adjustment items of profit attributable to shareholders --------------------------2K------------
Profit attributable to shareholders -14.33%20.57B-12.07%14.28B-5.04%7.48B7.07%33.48B4.37%24.01B7.44%16.24B3.84%7.88B13.23%31.27B11.43%23.01B15.43%15.12B
Basic earnings per share -14.13%0.784-12.07%0.532-5.25%0.2898.01%1.2944.82%0.9139.80%0.6053.74%0.30515.53%1.19819.15%0.87121.37%0.551
Diluted earnings per share -14.13%0.784-12.07%0.532-5.25%0.2897.85%1.2924.82%0.9139.80%0.6053.74%0.30515.53%1.19819.15%0.87121.37%0.551
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)------PricewaterhouseCoopers, PricewaterhouseCoopers Zhongtian (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data